tiprankstipranks
Ventas Inc (CH:VEN)
NYSE:VEN

Ventas (VEN) Price & Analysis

0 Followers

VEN Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
SHOP Operational MomentumSustained double-digit SHOP same-store NOI growth, rising occupancy and RevPOR reflect durable demand and pricing power in senior housing. This operational momentum improves cash flow predictability, supports margin expansion, and underpins scalable returns on new investments over the next several quarters.
Improving Cash GenerationConsistent gains in operating and free cash flow, with operating cash flow exceeding net income, indicate stronger earnings quality and internal funding capacity. Better cash conversion supports reinvestment, debt servicing and dividend coverage, enhancing financial resilience over a multi‑quarter horizon.
Capital Flexibility & LiquidityA $3B ATM and reported liquidity (~$5.5B at quarter end) provide durable capital flexibility to fund acquisitions, capex and lease-up investments. Access to equity markets and strong cash reserves reduce execution risk for growth plans and support opportunistic, relationship-driven deal sourcing.
Bears Say
Meaningful LeverageLeverage materially exceeds conservative REIT levels and net leverage (net debt/EBITDA ~5.0x) leaves less margin for rising rates or weaker operating performance. The noted TTM debt reporting inconsistency raises uncertainty around true indebtedness and constrains credit flexibility over coming quarters.
Lease-up And Stabilization RiskAcquisitions with sub‑stabilized occupancy require material leasing and capex to achieve underwriting yields. Execution risk on lease-ups and recent deliveries exposes near‑term cash flow volatility and delays expected NOI contributions, pressuring realized returns until stabilization is achieved.
Transaction Competition & Cap‑rate PressureCompression in acquisition cap rates reflects intense investor demand and raises the bar for future investment returns. Lower initial yields make it harder to achieve targeted ROIs without operational outperformance, increasing dependence on execution and potentially prompting more conservative deal pacing.

Ventas News

VEN FAQ

What was Ventas Inc’s price range in the past 12 months?
Currently, no data Available
What is Ventas Inc’s market cap?
Ventas Inc’s market cap is CHF38.75B.
    When is Ventas Inc’s upcoming earnings report date?
    Ventas Inc’s upcoming earnings report date is Jul 29, 2026 which is in 8 days.
      How were Ventas Inc’s earnings last quarter?
      Ventas Inc released its earnings results on Apr 27, 2026. The company reported $0.089 earnings per share for the quarter, missing the consensus estimate of $0.1 by -$0.011.
        Is Ventas Inc overvalued?
        According to Wall Street analysts Ventas Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ventas Inc pay dividends?
          Ventas Inc does not currently pay dividends.
          What is Ventas Inc’s EPS estimate?
          Ventas Inc’s EPS estimate is 0.12.
            How many shares outstanding does Ventas Inc have?
            Currently, no data Available
            What happened to Ventas Inc’s price movement after its last earnings report?
            Ventas Inc reported an EPS of $0.089 in its last earnings report, missing expectations of $0.1. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Ventas Inc?
              Currently, no hedge funds are holding shares in CH:VEN
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Ventas Inc

                As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.

                Ventas (VEN) Earnings & Revenues

                VEN Revenue Breakdown

                73.30%73.30%15.39%10.31%1.00%
                73.30% SHOP
                15.39% OM&R
                10.31% NNN
                1.00% Non-Segment
                tipranks

                VEN Stock 12 Month Forecast

                Average Price Target

                $79.70
                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
                Similar Stocks
                Company
                Price & Change
                Follow
                Healthpeak Properties
                Welltower
                Omega Healthcare
                Sabra Healthcare REIT
                Healthcare Realty Trust
                Popular Stocks